StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ)

Research analysts at StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Stock Performance

Shares of ENZ opened at $0.71 on Thursday. The company has a 50-day simple moving average of $0.99 and a two-hundred day simple moving average of $1.07. Enzo Biochem has a one year low of $0.68 and a one year high of $1.50.

Enzo Biochem (NYSE:ENZ) last announced its earnings results on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative net margin of 81.73% and a negative return on equity of 11.84%.

Institutional Investors Weigh In On Enzo Biochem

Several hedge funds have recently added to or reduced their stakes in the stock. XTX Topco Ltd raised its position in shares of Enzo Biochem by 94.5% in the 2nd quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after purchasing an additional 13,735 shares during the last quarter. BBR Partners LLC bought a new stake in Enzo Biochem during the 3rd quarter valued at about $112,000. Geode Capital Management LLC increased its stake in Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 11,742 shares in the last quarter. Finally, Renaissance Technologies LLC raised its holdings in Enzo Biochem by 2.6% in the second quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after buying an additional 64,417 shares during the last quarter. 36.90% of the stock is owned by institutional investors.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.